SCHEMBL9911378

SCHEMBL9911378

CC(C)C(C)(C)OCCN1CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HRH3 Q9Y5N1 2/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD1 P21728 1/20 0.38
TBXA2R P21731 1/20 0.38
ACHE P22303 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38
KDM4E B2RXH2 3/20 0.38
PSMB1 P20618 3/20 0.37
PSMB5 P28074 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9911374 0.96 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HRH3CHRM2HTR1A
SCHEMBL9911373 0.94 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HRH3CHRM2HTR1A
SCHEMBL9911372 0.86 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2HRH3CHRM2HTR1A
SCHEMBL9911460 0.83 SIGMAR1 (0.41) ALDH1A1SMN1; SMN2HSD17B10MEN1KMT2A
SCHEMBL9911455 0.80 KCNA3 (0.37) ALDH1A1HRH3ACHEKCNH2KDM4E
SCHEMBL9911499 0.80 HPGD (0.33) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MEN1
SCHEMBL10159897 0.79 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2HRH3CHRM2HTR1A
SCHEMBL19958953 0.77 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HRH3CHRM2HTR1A
SCHEMBL24856604 0.76 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2HRH3CHRM2HTR1A
SCHEMBL9911490 0.75 SLC6A4 (0.31) ALDH1A1SMN1; SMN2HRH3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198458-B2 Non-nucleoside reverse transcriptase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-12 US disclosed
US-20090143370-A1 Non-nucleoside Reverse Transcriptase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-04 US disclosed
US-7517998-B2 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2009-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143370-A1 Non-nucleoside Reverse Transcriptase Inhibitors RTF1, POLR1A, POLR1E ALDH1A1 411/4885SMN1; SMN2 1896/4885HRH3 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.